Chi Kin Wong
Chi Kin Wong is a postdoctoral scientist in Dr. Daniel Drucker’s lab at Mount Sinai Hospital in Toronto, where he studies the effects of GLP-1 medications on inflammation. He gained recognition for his research that demonstrated how semaglutide, a GLP-1 receptor agonist, can directly act on immune cells in the gut to reduce inflammation, which has implications for treating inflammatory diseases.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 8.00 | 0.09% | +0% | 38,005,238 | 34,899 | $1,700,000 | 1,561$ |
| Totals | 1 | 38,005,238 | 34,899 | $1,700,000 | 1,561$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dr. Chi Kin Wong studies how GLP-1s affect inflammation and commemorated his research with a tattoo of a Gila monster.
8